Teacher Retirement System of Texas bought a new position in shares of Revvity Inc. (NYSE:RVTY - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 17,807 shares of the company's stock, valued at approximately $1,884,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Assetmark Inc. boosted its holdings in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after purchasing an additional 259 shares during the period. Optiver Holding B.V. bought a new stake in shares of Revvity in the 4th quarter worth approximately $33,000. Quarry LP lifted its holdings in shares of Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after acquiring an additional 95 shares during the period. Millstone Evans Group LLC bought a new position in shares of Revvity during the 4th quarter worth about $38,000. Finally, Vermillion Wealth Management Inc. acquired a new stake in Revvity during the fourth quarter valued at approximately $41,000. Institutional investors and hedge funds own 86.65% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently weighed in on RVTY. Barclays lowered their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. JPMorgan Chase & Co. reduced their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Wells Fargo & Company reduced their price objective on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Raymond James Financial restated an "outperform" rating and issued a $120.00 target price (down from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Finally, UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and reduced their price target for the stock from $145.00 to $115.00 in a research report on Thursday, May 1st. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Revvity currently has an average rating of "Moderate Buy" and a consensus price target of $123.07.
Read Our Latest Stock Analysis on Revvity
Revvity Stock Down 0.9%
RVTY stock traded down $0.91 during mid-day trading on Friday, hitting $101.49. 676,357 shares of the company were exchanged, compared to its average volume of 975,197. Revvity Inc. has a 1-year low of $87.70 and a 1-year high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.99 and a current ratio of 3.58. The firm's 50 day simple moving average is $94.56 and its 200 day simple moving average is $104.61. The firm has a market cap of $11.96 billion, a P/E ratio of 43.19, a P/E/G ratio of 2.53 and a beta of 0.98.
Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. Revvity's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.98 EPS. On average, sell-side analysts predict that Revvity Inc. will post 4.94 EPS for the current fiscal year.
Revvity Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity's dividend payout ratio (DPR) is presently 11.91%.
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Featured Stories

Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.